index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

121 Publications with fulltext

Open Access

53 %

Mots clés

Analyses multidimensionnelles Adult Myocarditis Arthritis Assisted communication devices Autoantibodies Anti-IgE IgG Autoimmunity Deep immune profiling Biomarqueurs Anémie hémolytique Multidisciplinarity Biomarkers CD8+T cells Aldostérone B-lymphocyte Myopathy IBM Dependovirus/genetics/immunology Antibody responses B cell homeostasis Immunotherapy Antiphospholipid syndrome Inflammatory myopathy Cytokines Anti-drug antibodies Inborn errors of metabolism Antisynthétase Antibodies AAV Auto‐antibodies Immune checkpoint inhibitors DM Interstitial lung disease AAV antibody Auto-antibodies Middle Aged Adjudication Idiopathic inflammatory myopathies Myositis and muscle disease Anticorps anti-agalsidase Skeletal muscle Systems biology Polymyositis CD8+ T-bet+ cells Animals Myositis Adeno-associated vector Amyotrophic lateral sclerosis Biopsy Autoantibody AAV vectors Antisynthetase syndrome Prognosis Active Female COVID-19 Biomarker Anti-agalsidase antibodies Bioelectrical impedance analysis Anti-interleukin-6 Autoimmune diseases Adverse drug reactions Anti-synthetase syndrome Outcome measures Data integration Interferon Acute Kidney Injury/epidemiology/etiology Aged AAV vector Inclusion body myositis Anti-Mi2 Abnormal movement Dermatomyositis Male Adolescence Inflammation IMNM Aldosterone AAV humoral immunity Muscle Agalsidase Cancer Amyotrophy Anti‐mitochondrial antibodies Auto-immunité Adeno-associated virus Lysosomal storage diseases Acid-alpha-glucosidase Anticorps spécifique des myosites Mass cytometry Fabry disease Sphingosine-1-phosphate Humans Gene therapy Machine learning Adeno-associated virus vector Anti-MDA5 autoantibodies Antisynthetase Case reports